Alpha-fetoprotein expression is a potential prognostic marker in hepatocellular carcinoma
Dénes Görög1, János Regöly-Mérei, Sándor Paku
1Department of Transplantation and Surgery, Semmelweis University, Budapest H-1086, Hungary.
Aim:
To characterize the alpha-fetoprotein (AFP) positive and negative hepatocellular carcinoma (HCC) samples.
Methods:
Thirty-seven paraffin-embedded human HCC samples were analyzed by immunohistochemistry for the following antigens: AFP, beta-catenin, p53, CD44, MSH-2, MLH-1, and HNF-4. The tumors were divided into two groups based on the AFP expression. The immunophenotypic data and important clinical parameters were studied between the two groups.
Results:
Twenty-one of the thirty-seven examined HCCs were AFP positive. Seven with nuclear p53 staining were AFP positive, while seven tumors with nuclear beta-catenin staining were AFP negative. CD44 staining and high histological tumor grade were more frequent among the AFP-positive HCCs. The other immunophenotypical and clinical parameters did not show statistically significant difference in their distribution between the AFP positive and negative samples.
Conclusion:
AFP expression in HCC correlates with unfavorable prognostic factors, while nuclear beta-catenin positivity is more common among the AFP-negative liver tumors. This observation supports the microarray data on in vivo human tumors.
